Jiwa Bio-Pharm (HKG:2327) FY12 net profit $71M, dn 72%; div 2.1 ct - ResearchInChina

Search by Type

Report DataBase News

*

Category

Home>>News>>Life Sciences>>Pharmaceutical>>Pharmaceutical

Remember Me Next Time

Jiwa Bio-Pharm (HKG:2327) FY12 net profit $71M, dn 72%; div 2.1 ct

Date:2012/05/25

Related Company

Jiwa Bio-Pharm Holdings Limited(02327.HK)

Results of Jiwa Bio-Pharm Holdings (HKG:2327) for the fiscal year ended 31 March 2012:

Net profit: HK$70.62M, down 72.38% YoY
EPS: HK 4.39 cents
Final dividend: HK 2.1 cents

Source:chinesestock.org

Welcome to our website. This service is open to member only.

Registration

Contact our customer service team
Tel: 86-10-82600828, 82601561
Email: report@researchinchina.com

Related Reports

China Pharmaceutical Glass Packaging Industry Report, 2014-20172015-06-03

Related News

Shire Agrees to Talks After AbbVie Raises Bid, as Drug Firms Make Haste To Elude Tax2014-07-15
Mylan to Buy Abbott’s Generic Drug Business Outside U.S. for $5.3 Billion2014-07-15
As Vital Generic-Drug Prices Soar, So Do Pharmaceuticals’ Profits2014-07-15
Pharmaceutical Firms Find It Hard to Exit Essential Drugs Market2014-06-24
Major Pharmaceutical Groups May Be Too Big to Succeed2014-06-19
Fitch Sees Pharmaceutical Industry Maintaining Targeted M&A2014-06-10
Revenue and Net Income of Leading Vitamin Companies in China2014-06-05
Decentralising Drug Research2014-05-26

Contact us | Copyright | Privacy policy | Buy Reports | Member Service | Mailing List

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号